You haven't searched anything yet.
This is what you will do:
Alexion’s Product Development and Clinical Supply (PDCS) organization is seeking a synthetic organic chemist with expertise in flow chemistry, to serve as a subject matter expert with a substantial in-laboratory presence as we build our capability in drug substance continuous manufacturing. The Principal Scientist, Synthetic Product Development, will leverage expertise in flow chemistry to design safe, scalable, and cost-effective synthetic routes, with a special focus on development and deployment of advanced synthetic strategies enabled by multi-step continuous manufacturing.
You will be responsible for:
You will need to have:
We would prefer for you to have:
Expectation of working in the office 4 days a week statement: When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines. In-person working give us the platform we need to connect, work at pace and challenge perceptions. That’s why we work, on average, a minimum of four days per week from the office. But that doesn’t mean we’re not flexible. We balance the expectation of being in the office while respecting individual flexibility. Join us in our unique and ambitious world.
AstraZeneca embraces diversity and equality of opportunity. We are committed to building an inclusive and diverse team representing all backgrounds, with as wide a range of perspectives as possible, and harnessing industry-leading skills. We believe that the more inclusive we are, the better our work will be. We welcome and consider applications to join our team from all qualified candidates, regardless of their characteristics. We comply with all applicable laws and regulations on non-discrimination in employment (and recruitment), as well as work authorization and employment eligibility verification requirements.
Full Time
Pharmaceutical
$133k-167k (estimate)
05/21/2024
06/01/2024
astrazeneca-us.com
SOUTH SAN FRANCISCO, CA
7,500 - 15,000
Product/Brand/Service
TRUONG DANG
$1B - $3B
Pharmaceutical